A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination

被引:68
作者
Ravera, Mauro [1 ]
Gabano, Elisabetta [1 ]
Pelosi, Giorgio [2 ]
Fregonese, Federico [1 ]
Tinello, Stefano [1 ]
Osella, Domenico [1 ]
机构
[1] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, I-15121 Alessandria, Italy
[2] Univ Parma, Dipartimento Chim, I-43124 Parma, Italy
关键词
ANTICANCER COMPLEXES; ADDITION-REACTIONS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; ANTITUMOR AGENTS; AMMINE COMPLEXES; CHEMICAL-SHIFTS; CANCER-CELLS; REDUCTION; LIGANDS;
D O I
10.1021/ic501446b
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Pt(IV) complexes are usually prepared by oxidation of the corresponding Pt(II) counterparts, typically using hydrogen peroxide or chlorine. A different way to synthesize asymmetrical Pt(IV) compounds is the oxidative chlorination of Pt(II) counterparts with N-chlorosuccinimide. The reaction between cisplatin cis-[PtCl2(NH3)(2)], carboplatin, cis-[PtCl2(dach)] and cis-[Pt(cbdc)(dach)] (cbdc = cyclobutane-1,1'-dicarboxylato; dach = cyclohexane-1R,2R-diamine) with N-chlorosuccinimide in ethane-1,2-diol was optimized to produce the asymmetric Pt(IV) octahedral complexes [PtA(2)Cl-(glyc)X-2] (A(2) = 2 NH3 or dach; glyc = 2-hydroxyethanolato; X-2 = 2 Cl or cbdc) in high yield and purity. The X-ray crystal structure of the [Pt(cbdc)Cl(dach)(glyc)] complex is also reported. Moreover, the oxidation method proved to be versatile enough to produce other mixed Pt(IV) derivatives varying the reaction medium. The two trichlorido complexes easily undergo a pH-dependent hydrolysis reaction, whereas the dicarboxylato compounds are stable enough to allow further coupling reactions for drug targeting and delivery via the glyc reactive pendant. Therefore, the coupling reaction between the [Pt(cbdc)Cl(dach)(glyc)] and a model carboxylic acid, a model amine, and selectively protected amino acids is reported.
引用
收藏
页码:9326 / 9335
页数:10
相关论文
共 66 条
  • [1] Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates
    Abramkin, Sergey
    Valiahdi, Seied M.
    Jakupec, Michael A.
    Galanski, Markus
    Metzler-Nolte, Nils
    Keppler, Bernhard K.
    [J]. DALTON TRANSACTIONS, 2012, 41 (10) : 3001 - 3005
  • [2] Amblard Muriel, 2005, V298, P3
  • [3] Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake
    Ang, WH
    Pilet, S
    Scopelliti, R
    Bussy, F
    Juillerat-Jeanneret, L
    Dyson, PJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) : 8060 - 8069
  • [4] [Anonymous], 1974, INT TABLES XRAY CRYS, VIV
  • [5] N-15 AND PT-195 NMR-SPECTRA OF PLATINUM AMMINE COMPLEXES - TRANSINFLUENCE AND CIS-INFLUENCE SERIES BASED ON PT-195-N-15 COUPLING-CONSTANTS AND N-15 CHEMICAL-SHIFTS
    APPLETON, TG
    HALL, JR
    RALPH, SF
    [J]. INORGANIC CHEMISTRY, 1985, 24 (26) : 4685 - 4693
  • [6] Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes
    Barnes, KR
    Kutikov, A
    Lippard, SJ
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (04): : 557 - 564
  • [7] Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
    Barry, Nicolas P. E.
    Sadler, Peter J.
    [J]. ACS NANO, 2013, 7 (07) : 5654 - 5659
  • [8] Targeted delivery of platinum-based anticancer complexes
    Butler, Jennifer S.
    Sadler, Peter J.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2013, 17 (02) : 175 - 188
  • [9] Reduction of the anti-cancer drug analogue cis,trans,cis[PtCl2(OCOCH3)2(NH3)2] by L-cysteine and L-methionine and its crystal structure
    Chen, L
    Lee, PF
    Ranford, JD
    Vittal, JJ
    Wong, SY
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1999, (08): : 1209 - 1212
  • [10] Chen Y, 1998, CHEM-EUR J, V4, P672, DOI 10.1002/(SICI)1521-3765(19980416)4:4<672::AID-CHEM672>3.0.CO